- Home
- AKRO vs NBTB Comparison
AKRO vs NBTB Comparison
Compare AKRO & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- NBTB
- Stock Information
- Founded
- AKRO 2017
- NBTB 1856
- Country
- AKRO United States
- NBTB United States
- Employees
- AKRO N/A
- NBTB N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- NBTB Major Banks
- Sector
- AKRO Health Care
- NBTB Finance
- Exchange
- AKRO Nasdaq
- NBTB Nasdaq
- Market Cap
- AKRO 3.9B
- NBTB 2.2B
- IPO Year
- AKRO 2019
- NBTB N/A
- Fundamental
- Price
- AKRO $54.58
- NBTB $41.60
- Analyst Decision
- AKRO Strong Buy
- NBTB Buy
- Analyst Count
- AKRO 6
- NBTB 3
- Target Price
- AKRO $82.50
- NBTB $52.33
- AVG Volume (30 Days)
- AKRO 1.8M
- NBTB 214.3K
- Earning Date
- AKRO 08-08-2025
- NBTB 07-21-2025
- Dividend Yield
- AKRO N/A
- NBTB 3.25%
- EPS Growth
- AKRO N/A
- NBTB 17.05
- EPS
- AKRO N/A
- NBTB 3.03
- Revenue
- AKRO N/A
- NBTB $569,473,000.00
- Revenue This Year
- AKRO N/A
- NBTB $26.51
- Revenue Next Year
- AKRO N/A
- NBTB $12.04
- P/E Ratio
- AKRO N/A
- NBTB $13.83
- Revenue Growth
- AKRO N/A
- NBTB 13.26
- 52 Week Low
- AKRO $21.02
- NBTB $37.31
- 52 Week High
- AKRO $58.40
- NBTB $52.44
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- NBTB 52.06
- Support Level
- AKRO $53.05
- NBTB $40.53
- Resistance Level
- AKRO $56.49
- NBTB $41.88
- Average True Range (ATR)
- AKRO 2.44
- NBTB 0.82
- MACD
- AKRO -0.26
- NBTB 0.05
- Stochastic Oscillator
- AKRO 86.02
- NBTB 63.61
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.